CN115252520B - Composite plant extract and application thereof - Google Patents
Composite plant extract and application thereof Download PDFInfo
- Publication number
- CN115252520B CN115252520B CN202210931878.1A CN202210931878A CN115252520B CN 115252520 B CN115252520 B CN 115252520B CN 202210931878 A CN202210931878 A CN 202210931878A CN 115252520 B CN115252520 B CN 115252520B
- Authority
- CN
- China
- Prior art keywords
- extract
- ginseng
- tremella
- enzymolysis
- fermentation liquor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000419 plant extract Substances 0.000 title claims abstract description 61
- 239000002131 composite material Substances 0.000 title claims abstract description 33
- 239000000284 extract Substances 0.000 claims abstract description 94
- 241001506047 Tremella Species 0.000 claims abstract description 52
- 240000000111 Saccharum officinarum Species 0.000 claims abstract description 51
- 235000007201 Saccharum officinarum Nutrition 0.000 claims abstract description 51
- 235000017784 Mespilus germanica Nutrition 0.000 claims abstract description 31
- 244000182216 Mimusops elengi Species 0.000 claims abstract description 31
- 235000000560 Mimusops elengi Nutrition 0.000 claims abstract description 31
- 235000007837 Vangueria infausta Nutrition 0.000 claims abstract description 31
- 238000000108 ultra-filtration Methods 0.000 claims abstract description 30
- 235000020710 ginseng extract Nutrition 0.000 claims abstract description 27
- 229940015975 1,2-hexanediol Drugs 0.000 claims abstract description 20
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 claims abstract description 20
- 244000241838 Lycium barbarum Species 0.000 claims abstract description 16
- 235000015459 Lycium barbarum Nutrition 0.000 claims abstract description 16
- 150000001875 compounds Chemical class 0.000 claims abstract description 13
- 239000002537 cosmetic Substances 0.000 claims abstract description 11
- 235000015468 Lycium chinense Nutrition 0.000 claims abstract description 9
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 claims abstract description 8
- 238000010563 solid-state fermentation Methods 0.000 claims abstract description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 106
- 238000000855 fermentation Methods 0.000 claims description 68
- 230000004151 fermentation Effects 0.000 claims description 68
- 239000000203 mixture Substances 0.000 claims description 52
- 238000002156 mixing Methods 0.000 claims description 48
- 239000000843 powder Substances 0.000 claims description 40
- 241000208340 Araliaceae Species 0.000 claims description 38
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 38
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 38
- 235000008434 ginseng Nutrition 0.000 claims description 38
- 239000007787 solid Substances 0.000 claims description 35
- 239000001963 growth medium Substances 0.000 claims description 32
- 239000002245 particle Substances 0.000 claims description 32
- 230000001954 sterilising effect Effects 0.000 claims description 27
- 239000006071 cream Substances 0.000 claims description 26
- 238000004659 sterilization and disinfection Methods 0.000 claims description 24
- 244000248557 Ophiopogon japonicus Species 0.000 claims description 23
- 108090000790 Enzymes Proteins 0.000 claims description 21
- 102000004190 Enzymes Human genes 0.000 claims description 21
- 229940088598 enzyme Drugs 0.000 claims description 21
- 239000007788 liquid Substances 0.000 claims description 19
- 230000032683 aging Effects 0.000 claims description 17
- 238000004140 cleaning Methods 0.000 claims description 17
- 238000001035 drying Methods 0.000 claims description 17
- 239000006228 supernatant Substances 0.000 claims description 17
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims description 16
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims description 16
- 239000011324 bead Substances 0.000 claims description 16
- 239000006185 dispersion Substances 0.000 claims description 16
- 230000000415 inactivating effect Effects 0.000 claims description 16
- 235000010413 sodium alginate Nutrition 0.000 claims description 16
- 239000000661 sodium alginate Substances 0.000 claims description 16
- 229940005550 sodium alginate Drugs 0.000 claims description 16
- 238000012216 screening Methods 0.000 claims description 14
- 108010059892 Cellulase Proteins 0.000 claims description 12
- 241000186660 Lactobacillus Species 0.000 claims description 12
- 229940106157 cellulase Drugs 0.000 claims description 12
- 229930195210 Ophiopogon Natural products 0.000 claims description 11
- 230000002255 enzymatic effect Effects 0.000 claims description 10
- 238000000227 grinding Methods 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 9
- 238000007873 sieving Methods 0.000 claims description 8
- 239000002562 thickening agent Substances 0.000 claims description 8
- 230000007071 enzymatic hydrolysis Effects 0.000 claims description 7
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 claims description 7
- 239000012528 membrane Substances 0.000 claims description 7
- 241000235342 Saccharomycetes Species 0.000 claims description 6
- 239000003995 emulsifying agent Substances 0.000 claims description 6
- 239000003906 humectant Substances 0.000 claims description 6
- 239000003755 preservative agent Substances 0.000 claims description 6
- 230000002335 preservative effect Effects 0.000 claims description 6
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 claims description 5
- 108090000145 Bacillolysin Proteins 0.000 claims description 3
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 claims description 3
- 102000035092 Neutral proteases Human genes 0.000 claims description 3
- 108091005507 Neutral proteases Proteins 0.000 claims description 3
- 108090000526 Papain Proteins 0.000 claims description 3
- 102000057297 Pepsin A Human genes 0.000 claims description 3
- 108090000284 Pepsin A Proteins 0.000 claims description 3
- 239000004365 Protease Substances 0.000 claims description 3
- 239000002738 chelating agent Substances 0.000 claims description 3
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 claims description 3
- 229940039696 lactobacillus Drugs 0.000 claims description 3
- 229940055729 papain Drugs 0.000 claims description 3
- 235000019834 papain Nutrition 0.000 claims description 3
- 229940111202 pepsin Drugs 0.000 claims description 3
- 150000002148 esters Chemical class 0.000 claims description 2
- 239000003921 oil Substances 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 abstract description 15
- 230000037394 skin elasticity Effects 0.000 abstract description 10
- 230000000694 effects Effects 0.000 abstract description 8
- 238000004519 manufacturing process Methods 0.000 abstract description 6
- 230000006872 improvement Effects 0.000 abstract description 4
- 230000003647 oxidation Effects 0.000 abstract description 4
- 238000007254 oxidation reaction Methods 0.000 abstract description 4
- 230000002045 lasting effect Effects 0.000 abstract description 3
- 230000014759 maintenance of location Effects 0.000 abstract description 3
- 240000002948 Ophiopogon intermedius Species 0.000 abstract 1
- 238000012360 testing method Methods 0.000 description 49
- 230000000052 comparative effect Effects 0.000 description 43
- 239000002994 raw material Substances 0.000 description 27
- 239000008367 deionised water Substances 0.000 description 23
- 229910021641 deionized water Inorganic materials 0.000 description 23
- 239000000243 solution Substances 0.000 description 23
- 210000000434 stratum corneum Anatomy 0.000 description 23
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 22
- 230000003020 moisturizing effect Effects 0.000 description 22
- 239000000047 product Substances 0.000 description 22
- 230000008859 change Effects 0.000 description 18
- TXFPEBPIARQUIG-UHFFFAOYSA-N 4'-hydroxyacetophenone Chemical compound CC(=O)C1=CC=C(O)C=C1 TXFPEBPIARQUIG-UHFFFAOYSA-N 0.000 description 16
- 238000001816 cooling Methods 0.000 description 13
- 238000010438 heat treatment Methods 0.000 description 13
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 12
- 241000196324 Embryophyta Species 0.000 description 11
- 238000005119 centrifugation Methods 0.000 description 10
- 238000005360 mashing Methods 0.000 description 10
- 238000003756 stirring Methods 0.000 description 10
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 9
- 238000001914 filtration Methods 0.000 description 8
- 235000011187 glycerol Nutrition 0.000 description 8
- 229920001282 polysaccharide Polymers 0.000 description 7
- 239000005017 polysaccharide Substances 0.000 description 7
- 210000003491 skin Anatomy 0.000 description 7
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 6
- 238000000605 extraction Methods 0.000 description 6
- 150000004676 glycans Chemical class 0.000 description 6
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 6
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 6
- 229960002216 methylparaben Drugs 0.000 description 6
- 229960005323 phenoxyethanol Drugs 0.000 description 6
- 239000000523 sample Substances 0.000 description 6
- 230000009849 deactivation Effects 0.000 description 5
- 238000011010 flushing procedure Methods 0.000 description 5
- 230000002431 foraging effect Effects 0.000 description 5
- 238000000643 oven drying Methods 0.000 description 5
- 239000008223 sterile water Substances 0.000 description 5
- LXAHHHIGZXPRKQ-UHFFFAOYSA-N 5-fluoro-2-methylpyridine Chemical compound CC1=CC=C(F)C=N1 LXAHHHIGZXPRKQ-UHFFFAOYSA-N 0.000 description 4
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 4
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 229930003268 Vitamin C Natural products 0.000 description 4
- 229940098773 bovine serum albumin Drugs 0.000 description 4
- 230000001804 emulsifying effect Effects 0.000 description 4
- 238000011049 filling Methods 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 235000019154 vitamin C Nutrition 0.000 description 4
- 239000011718 vitamin C Substances 0.000 description 4
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 3
- 201000004624 Dermatitis Diseases 0.000 description 3
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 229960003237 betaine Drugs 0.000 description 3
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 239000002075 main ingredient Substances 0.000 description 3
- -1 polydimethylsiloxane Polymers 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- 244000241872 Lycium chinense Species 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- ILMMCBFQWHPTHE-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O.CCCC(O)O ILMMCBFQWHPTHE-UHFFFAOYSA-N 0.000 description 2
- 235000010418 carrageenan Nutrition 0.000 description 2
- 239000000679 carrageenan Substances 0.000 description 2
- 229920001525 carrageenan Polymers 0.000 description 2
- 229940113118 carrageenan Drugs 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 2
- 235000019441 ethanol Nutrition 0.000 description 2
- 230000036074 healthy skin Effects 0.000 description 2
- BTFJIXJJCSYFAL-UHFFFAOYSA-N icosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 2
- 230000036542 oxidative stress Effects 0.000 description 2
- 239000002516 radical scavenger Substances 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 239000011550 stock solution Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 2
- OMIGHNLMNHATMP-UHFFFAOYSA-N 2-hydroxyethyl prop-2-enoate Chemical compound OCCOC(=O)C=C OMIGHNLMNHATMP-UHFFFAOYSA-N 0.000 description 1
- UIVPNOBLHXUKDX-UHFFFAOYSA-N 3,5,5-trimethylhexyl 3,5,5-trimethylhexanoate Chemical compound CC(C)(C)CC(C)CCOC(=O)CC(C)CC(C)(C)C UIVPNOBLHXUKDX-UHFFFAOYSA-N 0.000 description 1
- DHFUFHYLYSCIJY-WSGIOKLISA-N CCCCCCCCCCCCCCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O Chemical compound CCCCCCCCCCCCCCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O DHFUFHYLYSCIJY-WSGIOKLISA-N 0.000 description 1
- SBJKKFFYIZUCET-JLAZNSOCSA-N Dehydro-L-ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(=O)C1=O SBJKKFFYIZUCET-JLAZNSOCSA-N 0.000 description 1
- SBJKKFFYIZUCET-UHFFFAOYSA-N Dehydroascorbic acid Natural products OCC(O)C1OC(=O)C(=O)C1=O SBJKKFFYIZUCET-UHFFFAOYSA-N 0.000 description 1
- 229940123457 Free radical scavenger Drugs 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 229920002367 Polyisobutene Polymers 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- HAMNKKUPIHEESI-UHFFFAOYSA-N aminoguanidine Chemical compound NNC(N)=N HAMNKKUPIHEESI-UHFFFAOYSA-N 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- FNAQSUUGMSOBHW-UHFFFAOYSA-H calcium citrate Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FNAQSUUGMSOBHW-UHFFFAOYSA-H 0.000 description 1
- 239000001354 calcium citrate Substances 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 235000020960 dehydroascorbic acid Nutrition 0.000 description 1
- 239000011615 dehydroascorbic acid Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- MGJZITXUQXWAKY-UHFFFAOYSA-N diphenyl-(2,4,6-trinitrophenyl)iminoazanium Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1N=[N+](C=1C=CC=CC=1)C1=CC=CC=C1 MGJZITXUQXWAKY-UHFFFAOYSA-N 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 229940100554 isononyl isononanoate Drugs 0.000 description 1
- 230000006651 lactation Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 1
- 230000008557 oxygen metabolism Effects 0.000 description 1
- 238000010831 paired-sample T-test Methods 0.000 description 1
- 238000011056 performance test Methods 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000008055 phosphate buffer solution Substances 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229940068977 polysorbate 20 Drugs 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 230000036559 skin health Effects 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 235000013337 tricalcium citrate Nutrition 0.000 description 1
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9728—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/805—Corresponding aspects not provided for by any of codes A61K2800/81 - A61K2800/95
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/85—Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a compound plant extract and application thereof. The composite plant extract comprises the following components in percentage by mass: ginseng extract: 26% -68%; wolfberry extract: 10% -20%; tremella extract: 10% -20%; radix Ophiopogonis extract: 5% -15%; sugarcane root extract: 5% -15%; 1, 2-hexanediol: 1% -2%; 1, 2-pentanediol: 1% -2%; the ginseng extract, the medlar extract, the tremella extract, the dwarf lilyturf tuber extract and the sugarcane root extract are prepared by solid state fermentation, enzymolysis and ultrafiltration. The composite plant extract has the effects of lasting moisture retention, oxidation resistance, saccharification resistance, skin elasticity improvement and the like, has simple preparation process and low production cost, can be applied to various cosmetics, and is suitable for large-scale industrial application.
Description
Technical Field
The invention relates to the technical field of skin care, in particular to a composite plant extract and application thereof.
Background
The plant extract is a substance obtained by extracting or processing a plant (whole or a part of a plant) as a raw material with a suitable solvent or method, and can be used in various fields such as medicine, food, daily chemicals, and the like. At present, one or more plant extracts are added to many cosmetics, but the following problems are common: 1) Although the plant extract with a single component can exert certain effect, the action mechanism of the plant extract is single, the function is single, and the effect which can be exerted by the plant extract is greatly reduced due to the influence of a formula system or certain components in the formula; 2) Plant extracts added in cosmetic formulations are generally difficult to effectively absorb by the skin and have very limited practical effects.
Therefore, the development of the compound plant extract with various effects of lasting moisture preservation, oxidation resistance, saccharification resistance, skin elasticity improvement and the like has very important significance.
Disclosure of Invention
One of the objects of the present invention is to provide a complex plant extract.
The second object of the present invention is to provide a moisturizing composition to which the composite plant extract of the present invention is added.
The technical scheme adopted by the invention is as follows:
a composite plant extract, which comprises the following components in percentage by mass:
ginseng extract: 26% -68%;
wolfberry extract: 10% -20%;
tremella extract: 10% -20%;
radix Ophiopogonis extract: 5% -15%;
sugarcane root extract: 5% -15%;
1, 2-hexanediol: 1% -2%;
1, 2-pentanediol: 1% -2%;
the ginseng extract, the medlar extract, the tremella extract, the dwarf lilyturf tuber extract and the sugarcane root extract are prepared by solid state fermentation, enzymolysis and ultrafiltration.
Preferably, the ginseng extract, the medlar extract, the tremella extract, the dwarf lilyturf tuber extract and the sugarcane root extract are prepared by the following methods:
1) Cleaning and drying plant raw materials, and performing superfine grinding and screening to obtain plant raw material powder;
2) Dispersing plant raw material powder with water, and then performing high-pressure sterilization to obtain a solid plant culture medium;
3) Uniformly mixing the activated bacterial liquid and the sterilized sodium alginate solution, then dripping the mixture into the sterilized calcium chloride solution to form gel beads, and then aging to obtain embedded strain particles;
4) Mixing the embedded strain particles with a solid plant culture medium, fermenting, adding water for dispersion, and centrifuging to obtain a supernatant to obtain a plant fermentation liquid;
5) Carrying out enzymolysis on the plant fermentation liquor to obtain an enzymatic hydrolysis plant fermentation liquor;
6) And (3) inactivating enzyme of the enzymatic plant fermentation broth, and performing ultrafiltration to obtain the plant extract.
Preferably, the ultrafiltration membrane used for ultrafiltration has a molecular weight cut-off of 1000Da to 2000Da.
Preferably, the ginseng extract is prepared by the following method:
1) Cleaning and drying ginseng, and then carrying out superfine grinding and screening to obtain ginseng powder;
2) Dispersing Ginseng radix powder with water, and sterilizing under high pressure to obtain solid Ginseng radix culture medium;
3) Uniformly mixing activated lactobacillus bacteria solution and sterilized sodium alginate solution, dripping into sterilized calcium chloride solution to form gel beads, and aging to obtain embedded strain particles;
4) Mixing the embedded strain particles with a solid ginseng culture medium, fermenting, adding water for dispersion, and centrifuging to obtain a supernatant to obtain ginseng fermentation liquor;
5) Adjusting the pH value of the ginseng fermentation liquor to 1.0-2.0, adding pepsin for primary enzymolysis, adjusting the pH value to 6.0-7.0, and adding papain for secondary enzymolysis to obtain the ginseng fermentation liquor for enzymolysis;
6) Inactivating enzyme of the fermented Ginseng radix liquid, and ultrafiltering to obtain Ginseng radix extract.
Preferably, the drying in step 1) is carried out at a temperature of 50-55 ℃.
Preferably, the screening in the step 1) adopts a 60-80 mesh screen.
Preferably, the adding amount ratio of the ginseng powder to the water in the step 2) is 1g:1.3 mL-1 g:2.5mL.
Preferably, the temperature of the high-pressure sterilization in the step 2) is 121 ℃, and the sterilization time is 20-30 min.
Preferably, the aging time in the step 3) is 10 min-15 min.
Preferably, the fermentation in the step 4) is carried out at 30-35 ℃ for 3-7 days.
Preferably, the specific operation of adding water for dispersion in the step 4) is as follows: adding the fermented product into water, wherein the mass ratio of the fermented product to the water is 1:8.5-9.5, mashing, and then placing in a constant-temperature water bath for ultrasonic vibration at 20-30 ℃ for 1.5-2 h.
Preferably, the centrifugation in the step 4) is performed under the condition that the rotation speed of the centrifugal machine is 4000 r/min-5000 r/min, and the centrifugation time is 15 min-25 min.
Preferably, the first enzymolysis in the step 5) is carried out at the temperature of 35-40 ℃ for 2.5-3 hours.
Preferably, the second enzymolysis in the step 5) is carried out at 50-60 ℃ for 2.5-3 hours.
Preferably, the enzyme deactivation in the step 6) is carried out at 100-105 ℃ for 5-10 min.
Preferably, the ultrafiltration in step 6) is performed under a pressure of 1.5MPa to 2.5 MPa.
Preferably, the wolfberry extract is prepared by the following method:
1) Cleaning and drying the medlar, and then carrying out superfine grinding and screening to obtain medlar powder;
2) Dispersing the medlar powder with water, and then performing high-pressure sterilization to obtain a solid medlar culture medium;
3) Uniformly mixing the activated saccharomycete liquid and the sterilized sodium alginate solution, dripping the mixture into the sterilized calcium chloride solution to form gel beads, and aging to obtain embedded strain particles;
4) Mixing the embedded strain particles with a solid medlar culture medium, fermenting, adding water for dispersion, and centrifuging to obtain supernatant to obtain medlar fermentation liquor;
5) Adjusting the pH value of the medlar fermentation broth to 6.0-7.0, and then adding cellulase and pectase for enzymolysis to obtain the enzymatic medlar fermentation broth;
6) And (3) inactivating enzyme of the enzymatic matrimony vine fermentation liquid, and performing ultrafiltration to obtain matrimony vine extract.
Preferably, the drying in step 1) is carried out at a temperature of 50-55 ℃.
Preferably, the screening in the step 1) adopts a 60-80 mesh screen.
Preferably, the adding amount ratio of the medlar powder to the water in the step 2) is 1g:1.3 mL-1 g:2.5mL.
Preferably, the temperature of the high-pressure sterilization in the step 2) is 121 ℃, and the sterilization time is 20-30 min.
Preferably, the aging time in the step 3) is 10 min-15 min.
Preferably, the fermentation in the step 4) is carried out at 30-35 ℃ for 3-7 days.
Preferably, the specific operation of adding water for dispersion in the step 4) is as follows: adding the fermented product into water, wherein the mass ratio of the fermented product to the water is 1:8.5-9.5, mashing, and then placing in a constant-temperature water bath for ultrasonic vibration at 20-30 ℃ for 1.5-2 h.
Preferably, the centrifugation in the step 4) is performed under the condition that the rotation speed of the centrifugal machine is 4000 r/min-5000 r/min, and the centrifugation time is 15 min-25 min.
Preferably, the enzymolysis in the step 5) is carried out at 40-50 ℃ for 2.5-3 hours.
Preferably, the enzyme deactivation in the step 6) is carried out at 100-105 ℃ for 5-10 min.
Preferably, the ultrafiltration in step 6) is performed under a pressure of 1.5MPa to 2.5 MPa.
Preferably, the tremella extract is prepared by the following method:
1) Cleaning and drying tremella, and then carrying out superfine grinding and screening to obtain tremella powder;
2) Dispersing tremella powder with water, and then performing high-pressure sterilization to obtain a solid tremella culture medium;
3) Uniformly mixing the activated saccharomycete liquid, the activated lactobacillus liquid and the sterilized sodium alginate solution, dripping the mixture into the sterilized calcium chloride solution to form gel beads, and aging to obtain embedded strain particles;
4) Mixing the embedded strain particles with a solid tremella culture medium, fermenting, adding water for dispersion, and centrifuging to obtain a supernatant to obtain tremella fermentation liquor;
5) Adjusting the pH value of the tremella fermentation liquor to 6.0-7.0, and then adding cellulase, pectase and neutral protease for enzymolysis to obtain the tremella fermentation liquor for enzymolysis;
6) And (3) inactivating enzyme of the enzymatic tremella fermentation liquid, and performing ultrafiltration to obtain tremella extract.
Preferably, the drying in step 1) is carried out at a temperature of 50-55 ℃.
Preferably, the screening in the step 1) adopts a 60-80 mesh screen.
Preferably, the adding amount ratio of the tremella powder to the water in the step 2) is 1g:1.3 mL-1 g:2.5mL.
Preferably, the temperature of the high-pressure sterilization in the step 2) is 121 ℃, and the sterilization time is 20-30 min.
Preferably, the aging time in the step 3) is 10 min-15 min.
Preferably, the fermentation in the step 4) is carried out at 30-35 ℃ for 3-7 days.
Preferably, the specific operation of adding water for dispersion in the step 4) is as follows: adding the fermented product into water, wherein the mass ratio of the fermented product to the water is 1:8.5-9.5, mashing, and then placing in a constant-temperature water bath for ultrasonic vibration at 20-30 ℃ for 1.5-2 h.
Preferably, the centrifugation in the step 4) is performed under the condition that the rotation speed of the centrifugal machine is 4000 r/min-5000 r/min, and the centrifugation time is 15 min-25 min.
Preferably, the enzymolysis in the step 5) is carried out at 40-50 ℃ for 2.5-3 hours.
Preferably, the enzyme deactivation in the step 6) is carried out at 100-105 ℃ for 5-10 min.
Preferably, the ultrafiltration in step 6) is performed under a pressure of 1.5MPa to 2.5 MPa.
Preferably, the ophiopogon root extract is prepared by the following method:
1) Cleaning and drying radix Ophiopogonis, and micronizing and sieving to obtain radix Ophiopogonis powder;
2) Dispersing radix Ophiopogonis powder with water, and performing high-pressure sterilization to obtain solid radix Ophiopogonis culture medium;
3) Uniformly mixing activated lactobacillus bacteria solution and sterilized sodium alginate solution, dripping into sterilized calcium chloride solution to form gel beads, and aging to obtain embedded strain particles;
4) Mixing the embedded strain particles with a solid ophiopogon culture medium, fermenting, adding water for dispersion, and centrifuging to obtain supernatant to obtain ophiopogon fermentation liquor;
5) Adjusting the pH value of the ophiopogon japonicus fermentation liquor to 6.0-7.0, and then adding cellulase and pectase for enzymolysis to obtain the enzymolysis ophiopogon japonicus fermentation liquor;
6) And (3) inactivating enzyme of the enzymatic radix ophiopogonis fermentation liquid, and performing ultrafiltration to obtain the radix ophiopogonis extract.
Preferably, the drying in step 1) is carried out at a temperature of 50-55 ℃.
Preferably, the screening in the step 1) adopts a 60-80 mesh screen.
Preferably, the adding amount ratio of the dwarf lilyturf tuber powder to the water in the step 2) is 1g:1.3 mL-1 g:2.5mL.
Preferably, the temperature of the high-pressure sterilization in the step 2) is 121 ℃, and the sterilization time is 20-30 min.
Preferably, the aging time in the step 3) is 10 min-15 min.
Preferably, the fermentation in the step 4) is carried out at 30-35 ℃ for 3-7 days.
Preferably, the specific operation of adding water for dispersion in the step 4) is as follows: adding the fermented product into water, wherein the mass ratio of the fermented product to the water is 1:8.5-9.5, mashing, and then placing in a constant-temperature water bath for ultrasonic vibration at 20-30 ℃ for 1.5-2 h.
Preferably, the centrifugation in the step 4) is performed under the condition that the rotation speed of the centrifugal machine is 4000 r/min-5000 r/min, and the centrifugation time is 15 min-25 min.
Preferably, the enzymolysis in the step 5) is carried out at 40-50 ℃ for 2.5-3 hours.
Preferably, the enzyme deactivation in the step 6) is carried out at 100-105 ℃ for 5-10 min.
Preferably, the ultrafiltration in step 6) is performed under a pressure of 1.5MPa to 2.5 MPa.
Preferably, the sugarcane root extract is prepared by the following method:
1) Cleaning and drying the sugarcane roots, and carrying out superfine grinding and screening to obtain sugarcane root powder;
2) Dispersing the sugarcane root powder with water, and then performing high-pressure sterilization to obtain a solid sugarcane root culture medium;
3) Uniformly mixing activated lactobacillus bacteria solution and sterilized sodium alginate solution, dripping into sterilized calcium chloride solution to form gel beads, and aging to obtain embedded strain particles;
4) Mixing the embedded strain particles with a solid-state sugarcane root culture medium, fermenting, adding water for dispersion, and centrifuging to obtain supernatant to obtain sugarcane root fermentation liquor;
5) Adjusting the pH value of the sugarcane root fermentation liquor to 6.0-7.0, and then adding cellulase and pectase for enzymolysis to obtain the enzymatic hydrolysis sugarcane root fermentation liquor;
6) And (3) inactivating enzyme of the enzymatic hydrolysis sugarcane root fermentation liquor, and performing ultrafiltration to obtain the sugarcane root extract.
Preferably, the drying in step 1) is carried out at a temperature of 50-55 ℃.
Preferably, the screening in the step 1) adopts a 60-80 mesh screen.
Preferably, the adding amount ratio of the sugarcane root powder to the water in the step 2) is 1g:1.3 mL-1 g:2.5mL.
Preferably, the temperature of the high-pressure sterilization in the step 2) is 121 ℃, and the sterilization time is 20-30 min.
Preferably, the aging time in the step 3) is 10 min-15 min.
Preferably, the fermentation in the step 4) is carried out at 30-35 ℃ for 3-7 days.
Preferably, the specific operation of adding water for dispersion in the step 4) is as follows: adding the fermented product into water, wherein the mass ratio of the fermented product to the water is 1:8.5-9.5, mashing, and then placing in a constant-temperature water bath for ultrasonic vibration at 20-30 ℃ for 1.5-2 h.
Preferably, the centrifugation in the step 4) is performed under the condition that the rotation speed of the centrifugal machine is 4000 r/min-5000 r/min, and the centrifugation time is 15 min-25 min.
Preferably, the enzymolysis in the step 5) is carried out at 40-50 ℃ for 2.5-3 hours.
Preferably, the enzyme deactivation in the step 6) is carried out at 100-105 ℃ for 5-10 min.
Preferably, the ultrafiltration in step 6) is performed under a pressure of 1.5MPa to 2.5 MPa.
Use of the above compound plant extract in cosmetics.
The essence comprises the following components in percentage by mass:
humectant: 7% -12%;
chelating agent: 0.01 to 0.1 percent;
and (3) a thickening agent: 0.1 to 0.2 percent;
the above compound plant extract: 0.5% -20%;
preservative: 0.2% -1%;
water: 70% -90%.
Preferably, the humectant is at least one of glycerin, butylene glycol and betaine.
Preferably, the chelating agent is at least one of disodium EDTA and calcium citrate.
Preferably, the thickener is at least one of carrageenan and hydrolyzed polysaccharide gum.
Preferably, the preservative is at least 2 of p-hydroxyacetophenone, 1, 2-hexanediol, methylparaben and phenoxyethanol.
The essence cream comprises the following components in percentage by mass:
phase A:
humectant: 5% -10%; disodium EDTA: 0.01 to 0.1 percent; water: 60% -80%;
and B phase:
emulsifying agent: 1% -3%; oil ester: 5% -10%;
and C phase:
and (3) a thickening agent: 1% -2%;
and D phase:
the above compound plant extract: 0.5% -20%; preservative: 0.5 to 1.5 percent.
Preferably, the humectant is at least one of glycerin, butylene glycol and betaine.
Preferably, the emulsifier is emulsifier Montanov 82 (main ingredient: cetyl stearyl alcohol and cocoyl glucoside), emulsifier Montanov 202 (main ingredient: arachidyl alcohol, behenyl alcohol and arachidyl glucoside), and emulsifier SENSANOV WR (main ingredient: C) 20 ~C 22 Alcohol phosphate and C 20 ~C 22 Alcohol).
Preferably, the grease is at least one of caprylic/capric triglyceride, polydimethylsiloxane, isononyl isononanoate and mineral oil.
Preferably, the thickener is at least one of a thickener SEPINOV EMT 10 (main component: hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer), and a thickener SEPIPLUS 400 (main component: polyacrylate-13, polyisobutylene and polysorbate-20).
Preferably, the preservative is at least 2 of p-hydroxyacetophenone, 1, 2-hexanediol, methylparaben and phenoxyethanol.
The beneficial effects of the invention are as follows: the composite plant extract has the effects of lasting moisture retention, oxidation resistance, saccharification resistance, skin elasticity improvement and the like, has simple preparation process and low production cost, can be applied to various cosmetics, and is suitable for large-scale industrial application.
Specifically:
1) The compound plant extract is prepared from ginseng, medlar, tremella, dwarf lilyturf tuber and sugarcane roots through solid state fermentation, enzymolysis and ultrafiltration, so that the extraction rate of active ingredients is maximized, plant extracts containing a plurality of active ingredients such as polysaccharide, saponin, vitamin, amino acid, polypeptide and the like are obtained, the molecular weight of each active ingredient in the plant extracts is controlled below 2000Da through ultrafiltration, the efficient absorption of skin is facilitated, and in addition, the synergistic effect among the plurality of plant extracts can be fully exerted by compounding, and the action effect of the compound plant extract can be highlighted;
2) The composite plant extract has simple production process and low production cost, can be applied to various cosmetics, and is suitable for large-scale industrial application.
Detailed Description
The invention is further illustrated and described below in connection with specific examples.
Example 1:
a composite plant extract having the composition shown in the following table:
TABLE 1 composition of composite plant extracts
Raw materials | Mass percent (%) |
Ginseng extract | 47 |
Lycium barbarum extract | 15 |
Tremella extract | 15 |
Radix Ophiopogonis extract | 10 |
Sugarcane root extract | 10 |
1, 2-hexanediol | 1.5 |
1, 2-pentanediol | 1.5 |
Note that:
the ginseng extract is prepared by the following steps: 1) Cleaning Ginseng radix, oven drying at 55deg.C, micronizing with an ultrafine pulverizer, and sieving with 80 mesh sieve to obtain Ginseng radix powder; 2) Stirring and dispersing 10g of ginseng powder with 25mL of deionized water, and then filling into an autoclave, and performing high-pressure sterilization at 121 ℃ for 30min to obtain a solid ginseng culture medium; 3) Uniformly mixing activated lactobacillus bacteria solution and sterilized sodium alginate solution with the mass fraction of 3% according to the volume ratio of 1:5, dripping the mixture into sterilized calcium chloride solution with the mass fraction of 4% by using a syringe to form gel beads, standing for 10min for aging, filtering, and flushing the filtered solid with sterile water to obtain embedded strain particles; 4) Mixing the embedded strain particles with a solid ginseng culture medium, putting the mixture into a constant temperature vibration incubator, fermenting for 5 days at 35 ℃, adding the fermented product into deionized water, wherein the mass ratio of the fermented product to the deionized water is 1:9, mashing, putting the crushed mixture into a constant temperature water bath, ultrasonically vibrating the crushed mixture at 25 ℃ for 2 hours, centrifuging the mixture for 25 minutes at the rotation speed of a centrifuge of 5000r/min, and taking supernatant to obtain ginseng fermentation liquor; 5) Adjusting the pH value of the ginseng fermentation liquor to 1.5, adding pepsin, carrying out enzymolysis for 3 hours at 37 ℃, adjusting the pH value to 6.5, adding papain, carrying out enzymolysis for 3 hours at 50 ℃ to obtain an enzymolysis ginseng fermentation liquor; 6) Heating the enzymolysis Ginseng radix fermentation broth to 105deg.C, inactivating enzyme for 10min, cooling to 25deg.C, and ultrafiltering with ultrafiltration membrane with molecular weight cut-off of 2000Da under pressure of 2.5MPa to obtain Ginseng radix extract.
The medlar extract is prepared by the following steps: 1) Cleaning fructus Lycii, oven drying at 55deg.C, micronizing with an ultrafine pulverizer, and sieving with 80 mesh sieve to obtain fructus Lycii powder; 2) Stirring and dispersing 10g of medlar powder with 25mL of deionized water, and then filling the mixture into an autoclave, and carrying out high-pressure sterilization for 30min at 121 ℃ to obtain a solid medlar culture medium; 3) Uniformly mixing the activated saccharomycete liquid and a sterilized sodium alginate solution with the mass fraction of 3 percent according to the volume ratio of 1:5, dripping the mixture into a sterilized calcium chloride solution with the mass fraction of 4 percent by using a syringe to form gel beads, standing for 10 minutes for aging, filtering, and flushing the filtered solid by using sterile water to obtain embedded strain particles; 4) Mixing the embedded strain particles and a solid medlar culture medium, putting the mixture into a constant temperature vibration incubator, fermenting for 5 days at 35 ℃, adding the fermented product into deionized water, wherein the mass ratio of the fermented product to the deionized water is 1:9, mashing, putting the mixture into a constant temperature water bath, ultrasonically vibrating for 2 hours at 25 ℃, centrifuging for 25 minutes at the rotation speed of a centrifuge of 5000r/min, and taking supernatant to obtain medlar fermentation liquor; 5) Adjusting the pH value of the medlar fermentation broth to 6.5, adding cellulase and pectase, and performing enzymolysis for 3 hours at 50 ℃ to obtain the enzymatic medlar fermentation broth; 6) And (3) heating the enzymatic hydrolysis fermentation liquid of the Chinese wolfberry, inactivating enzyme for 10min after the temperature is raised to 105 ℃, cooling to 25 ℃, and performing ultrafiltration by using an ultrafiltration membrane with the molecular weight cutoff of 2000Da under the condition of the pressure of 2.5MPa to obtain the Chinese wolfberry extract.
The tremella extract is prepared by the following steps: 1) Cleaning Tremella, oven drying at 55deg.C, micronizing with an ultrafine pulverizer, and sieving with 60 mesh sieve to obtain Tremella powder; 2) Stirring and dispersing 10g of tremella powder with 25mL of deionized water, and then filling the tremella powder into an autoclave, and carrying out high-pressure sterilization for 30min at 121 ℃ to obtain a solid tremella culture medium; 3) Uniformly mixing the activated saccharomycete liquid, the activated lactobacillus liquid and the sterilized sodium alginate solution with the mass fraction of 3 percent according to the volume ratio of 1:1:8, dripping the mixture into the sterilized calcium chloride solution with the mass fraction of 4 percent by using a syringe to form gel beads, standing for 10 minutes for aging, filtering, and flushing the filtered solid by using sterile water to obtain embedded strain particles; 4) Mixing the embedded strain particles and a solid tremella culture medium, putting the mixture into a constant temperature vibration incubator, fermenting for 5 days at 35 ℃, adding the fermented product into deionized water, wherein the mass ratio of the fermented product to the deionized water is 1:9, mashing, putting the mixture into a constant temperature water bath, ultrasonically vibrating for 2 hours at 25 ℃, centrifuging for 25 minutes at the rotation speed of a centrifuge of 5000r/min, and taking supernatant to obtain tremella fermentation liquor; 5) Adjusting the pH value of the tremella fermentation liquor to 6.5, adding cellulase, pectase and neutral protease, and carrying out enzymolysis for 3 hours at 50 ℃ to obtain the tremella fermentation liquor subjected to enzymolysis; 6) And (3) heating the enzymatic tremella fermentation liquid to 105 ℃, inactivating enzymes for 10min, cooling to 25 ℃, and performing ultrafiltration with an ultrafiltration membrane with a molecular weight cutoff of 2000Da under the condition of 2.5MPa to obtain tremella extract.
The radix ophiopogonis extract is prepared by the following steps: 1) Cleaning radix Ophiopogonis, oven drying at 55deg.C, micronizing with an ultrafine pulverizer, and sieving with 60 mesh sieve to obtain radix Ophiopogonis powder; 2) Stirring and dispersing 10g of radix Ophiopogonis powder with 25mL of deionized water, and then placing into an autoclave, and performing high-pressure sterilization at 121 ℃ for 30min to obtain a solid radix Ophiopogonis culture medium; 3) Uniformly mixing activated lactobacillus bacteria solution and sterilized sodium alginate solution with the mass fraction of 3% according to the volume ratio of 1:5, dripping the mixture into sterilized calcium chloride solution with the mass fraction of 4% by using a syringe to form gel beads, standing for 10min for aging, filtering, and flushing the filtered solid with sterile water to obtain embedded strain particles; 4) Mixing the embedded strain particles and a solid ophiopogon culture medium, putting the mixture into a constant temperature vibration incubator, fermenting for 5 days at 35 ℃, adding the fermented product into deionized water, wherein the mass ratio of the fermented product to the deionized water is 1:9, mashing, putting the crushed mixture into a constant temperature water bath, ultrasonically vibrating for 2 hours at 25 ℃, centrifuging for 25 minutes at the rotation speed of a centrifuge of 5000r/min, and taking supernatant to obtain ophiopogon fermentation liquor; 5) Adjusting the pH value of the ophiopogon japonicus fermentation liquor to 6.5, adding cellulase and pectase, and carrying out enzymolysis for 3 hours at 50 ℃ to obtain the enzymolysis ophiopogon japonicus fermentation liquor; 6) Heating the enzymolysis radix Ophiopogonis fermentation broth to 105deg.C, inactivating enzyme for 10min, cooling to 25deg.C, and ultrafiltering with ultrafiltration membrane with molecular weight cut-off of 2000Da under pressure of 2.5MPa to obtain radix Ophiopogonis extract.
The sugarcane root extract is prepared by the following steps: 1) Cleaning the sugarcane roots, drying at 55 ℃, carrying out superfine grinding by using a superfine grinder, and then sieving by using a 60-mesh screen to obtain sugarcane root powder; 2) Stirring and dispersing 10g of sugarcane root powder with 25mL of deionized water, and then filling the mixture into an autoclave, and carrying out high-pressure sterilization for 30min at 121 ℃ to obtain a solid sugarcane root culture medium; 3) Uniformly mixing activated lactobacillus bacteria solution and sterilized sodium alginate solution with the mass fraction of 3% according to the volume ratio of 1:5, dripping the mixture into sterilized calcium chloride solution with the mass fraction of 4% by using a syringe to form gel beads, standing for 10min for aging, filtering, and flushing the filtered solid with sterile water to obtain embedded strain particles; 4) Mixing the embedded strain particles and a solid sugarcane root culture medium, putting the mixture into a constant-temperature vibration incubator, fermenting for 5 days at 35 ℃, adding the fermented product into deionized water, wherein the mass ratio of the fermented product to the deionized water is 1:9, mashing, putting the crushed mixture into a constant-temperature water bath, ultrasonically vibrating for 2 hours at 25 ℃, centrifuging for 25 minutes at the rotation speed of a centrifuge of 5000r/min, and taking supernatant to obtain sugarcane root fermentation liquor; 5) Adjusting the pH value of the sugarcane root fermentation liquor to 6.5, adding cellulase and pectase, and carrying out enzymolysis for 3 hours at 50 ℃ to obtain the enzymolysis sugarcane root fermentation liquor; 6) Heating the enzymatic hydrolysis fermentation liquor of the sugarcane roots to 105 ℃, inactivating enzymes for 10min, cooling to 25 ℃, and performing ultrafiltration by using an ultrafiltration membrane with a molecular weight cut-off of 2000Da under the condition of 2.5MPa to obtain the sugarcane root extract.
Example 2:
a composite plant extract having the composition shown in the following table:
TABLE 2 composition of composite plant extracts
Raw materials | Mass percent (%) |
Ginseng extract | 49 |
Lycium barbarum extract | 13 |
Tremella extract | 15 |
Radix Ophiopogonis extract | 5 |
Sugarcane root extract | 15 |
1, 2-hexanediol | 2 |
1, 2-pentanediol | 1 |
Note that: the preparation methods of ginseng extract, wolfberry extract, tremella extract, ophiopogon root extract and sugarcane root extract are the same as in example 1.
Example 3:
a composite plant extract having the composition shown in the following table:
TABLE 3 composition of composite plant extracts
Raw materials | Mass percent (%) |
Ginseng extract | 37 |
Lycium barbarum extract | 20 |
Tremella extract | 20 |
Radix Ophiopogonis extract | 10 |
Sugarcane root extract | 10 |
1, 2-hexanediol | 1.5 |
1, 2-pentanediol | 1.5 |
Note that: the preparation methods of ginseng extract, wolfberry extract, tremella extract, ophiopogon root extract and sugarcane root extract are the same as in example 1.
Example 4:
a composite plant extract having the composition shown in the following table:
TABLE 4 composition of composite plant extracts
Raw materials | Mass percent (%) |
Ginseng extract | 27 |
Lycium barbarum extract | 20 |
Tremella extract | 20 |
Radix Ophiopogonis extract | 15 |
Sugarcane root extract | 15 |
1, 2-hexanediol | 1 |
1, 2-pentanediol | 2 |
Note that: the preparation methods of ginseng extract, wolfberry extract, tremella extract, ophiopogon root extract and sugarcane root extract are the same as in example 1.
Comparative example 1:
a composite plant extract having the composition shown in the following table:
TABLE 5 composition of composite plant extracts
Raw materials | Mass percent (%) |
Ginseng extract | 47 |
Lycium barbarum extract | 15 |
Tremella extract | 15 |
Radix Ophiopogonis extract | 10 |
Sugarcane root extract | 10 |
1, 2-hexanediol | 1.5 |
1, 2-pentanediol | 1.5 |
Note that:
the ginseng extract is prepared by the following steps: 1) Cleaning Ginseng radix, oven drying at 55deg.C, micronizing with an ultrafine pulverizer, and sieving with 80 mesh sieve to obtain Ginseng radix powder; 2) Dispersing 10g of ginseng powder with 90mL of deionized water under stirring, soaking for 1h, decocting at 80 ℃ for 1h, filtering, adding filter residues into 90mL of deionized water, decocting at 80 ℃ for 1h, filtering, combining the two filtrates, concentrating to 10mL, centrifuging at a centrifuge rotating speed of 5000r/min for 25min, filtering and sterilizing the supernatant to obtain the ginseng extract.
The preparation method of the medlar extract, the tremella extract, the dwarf lilyturf tuber extract and the sugarcane root extract is the same as that of the ginseng extract.
Comparative example 2:
ginseng radix extract (preparation method is the same as in example 1).
Application example 1:
an essence, the composition of which is shown in the following table:
TABLE 6 composition of essence
Raw materials | Mass percent (%) |
Glycerol | 6.0 |
Butanediol (butanediol) | 4.0 |
EDTA disodium salt | 0.02 |
Hydrolyzed polysaccharide gum | 0.1 |
The Complex plant extract of example 1 | 3.0 |
Para hydroxy acetophenone | 0.5 |
1, 2-hexanediol | 0.5 |
Deionized water | 85.88 |
The preparation method of the essence comprises the following steps: dissolving glycerol, butanediol, EDTA disodium and hydrolyzed polysaccharide gum in deionized water, heating to 80deg.C, maintaining the temperature for 20min, cooling to 45deg.C, adding the compound plant extract of example 1 and p-hydroxyacetophenone and 1, 2-hexanediol, and mixing to obtain essence.
Application example 2:
an essence, the composition of which is shown in the following table:
TABLE 7 composition of essence
The preparation method of the essence comprises the following steps: dissolving glycerol, betaine, EDTA disodium and carrageenan in deionized water, heating to 80deg.C, maintaining the temperature for 20min, cooling to 45deg.C, adding the compound plant extract of example 1, preheating and mixing to transparent 1, 2-hexanediol, methylparaben and phenoxyethanol, and mixing to obtain essence.
Application example 3:
an essence cream, the composition of which is shown in the following table:
table 8 composition table of essence cream
The preparation method of the essence cream comprises the following steps: mixing and stirring the phase A raw material and the phase B raw material respectively, heating to 85 ℃, adding the phase B raw material into the phase A raw material, homogenizing and emulsifying for 6min, adding the phase C, homogenizing for 6min again, preserving heat for 20min, cooling to 45 ℃, adding the composite plant extract of the embodiment 1 in the phase D, preheating and dissolving to transparent p-hydroxyacetophenone and 1, 2-hexanediol, and uniformly mixing to obtain the essence cream.
Application example 4:
an essence cream, the composition of which is shown in the following table:
table 9 composition table of essence cream
The preparation method of the essence cream comprises the following steps: mixing and stirring the phase A raw material and the phase B raw material respectively, heating to 85 ℃, adding the phase B raw material into the phase A raw material, homogenizing and emulsifying for 6min, adding the phase C, homogenizing for 6min again, preserving heat for 20min, cooling to 45 ℃, adding the composite plant extract of the embodiment 1 in the phase D, and preheating to dissolve to transparent 1, 2-hexanediol, methylparaben and phenoxyethanol, and mixing uniformly to obtain the essence cream.
Comparative application example 1:
an essence, the composition of which is shown in the following table:
table 10 composition table of essence
The preparation method of the essence comprises the following steps: dissolving glycerol, butanediol, EDTA disodium and hydrolyzed polysaccharide gum in deionized water, heating to 80deg.C, maintaining the temperature for 20min, cooling to 45deg.C, adding the compound plant extract of comparative example 1, preheating and mixing to transparent p-hydroxyacetophenone and 1, 2-hexanediol, and mixing to obtain essence.
Comparative application example 2:
an essence, the composition of which is shown in the following table:
table 11 composition table of essence
Raw materials | Mass percent (%) |
Glycerol | 6.0 |
Butanediol (butanediol) | 4.0 |
EDTA disodium salt | 0.02 |
Hydrolysis of polysaccharide acids | 0.1 |
Ginseng radix extract of comparative example 2 | 3.0 |
Para hydroxy acetophenone | 0.5 |
1, 2-hexanediol | 0.5 |
Deionized water | 85.88 |
The preparation method of the essence comprises the following steps: dissolving glycerol, butanediol, EDTA disodium and hydrolyzed polysaccharide gum in deionized water, heating to 80deg.C, maintaining the temperature for 20min, cooling to 45deg.C, adding Ginseng radix extract of comparative example 2, preheating and mixing to transparent p-hydroxyacetophenone and 1, 2-hexanediol, and mixing to obtain essence.
Comparative application example 3:
an essence cream, the composition of which is shown in the following table:
table 12 composition table of essence cream
The preparation method of the essence cream comprises the following steps: and respectively mixing and stirring the phase A raw material and the phase B raw material uniformly, heating to 85 ℃, adding the phase B raw material into the phase A raw material, homogenizing and emulsifying for 6min, adding the phase C, homogenizing for 6min again, preserving heat for 20min, cooling to 45 ℃, adding the composite plant extract of the comparative example 1 in the phase D, and preheating to dissolve to transparent 1, 2-hexanediol, methylparaben and phenoxyethanol, and uniformly mixing to obtain the essence cream.
Comparative application example 4:
an essence cream, the composition of which is shown in the following table:
TABLE 13 composition of essence cream
The preparation method of the essence cream comprises the following steps: mixing and stirring the phase A raw material and the phase B raw material respectively, heating to 85 ℃, adding the phase B raw material into the phase A raw material, homogenizing and emulsifying for 6min, adding the phase C, homogenizing for 6min again, preserving heat for 20min, cooling to 45 ℃, adding the ginseng extract of comparative example 2 in the phase D, and preheating to dissolve to transparent 1, 2-hexanediol, methylparaben and phenoxyethanol, and mixing uniformly to obtain the essence cream.
Comparative application example 5:
european Bedses moisturizing repair stock (Guangzhou, makeup Co., ltd.).
Comparative application example 6:
european Bei Sishui moisturizing cream (Guangzhou City, makeup Co., ltd.).
Performance test:
1) Determination of skin moisture content:
test standard: QB/T4256-2011, cosmetic moisturizing efficacy evaluation guide.
Test object: 200 volunteers aged 18 to 60 years (without limitation for men and women, except for gestational and lactating women), had healthy skin, no history of skin allergy, and no other clinical trial was taken in the test sites for nearly three months, and 200 volunteers were randomly divided into 8 groups (designated as group A, group B, group C, group D, group E, group F, group G and group H) of 25 persons each.
Test environment: the temperature is 20-22 ℃ and the relative humidity is 40-60%, and the real-time dynamic detection is carried out.
The testing method comprises the following steps:
a) Any product cannot be used 2-3 days before the test of the tested part, water cannot be contacted for 1-3 hours, a mark of 3cm multiplied by 3cm is made on the inner side of the forearm, the tested part is wiped by dry facial tissue before the test, and then the tested part is stood still for 20min;
b) H 0 (blank test): the test areas were measured in parallel 3 times using a MoistureMeter SC stratum corneum moisture content measuring instrument, with the test samples at 2.0mg/cm 2 ±0.1mg/cm 2 Single coating is carried out on the dosage of the (B) and the actual coating sample quantity is recorded;
c) 1h (experimental test): measuring the test area by using a MoistureMeter SC stratum corneum water content measuring instrument, and carrying out parallel measurement for 3 times; h 2 (experimental test): measuring the test area by using a MoistureMeter SC stratum corneum water content measuring instrument, and carrying out parallel measurement for 3 times; h 4 (experimental test): measuring the test area by using a MoistureMeter SC stratum corneum water content measuring instrument, and carrying out parallel measurement for 3 times;
d) The essence of application example 1 is used in group a, the essence of application example 4 is used in group B, the essence of comparative application example 1 is used in group C, the essence of comparative application example 3 is used in group D, the essence of comparative application example 2 is used in group E, the essence of comparative application example 4 is used in group F, the European style moisturizing and repairing stock of comparative application example 5 is used in group G, and the European style Bei Sishui moisturizing and repairing cream of comparative application example 6 is used in group H.
The test indexes are as follows:
a) The higher the moisture content of the stratum corneum, the higher the value, indicating a higher moisture content of the stratum corneum;
b) Percent change (%) = (n hours number-0 hours number)/0 hours number x 100%;
c) Total effective rate (%) =effective number/total number×100%.
Calculating a test result:
a) Descriptive statistics are carried out on the measured values of all the test areas, wherein the descriptive statistics comprise average values, standard deviations, minimum values, median values and maximum values;
b) Using SPSS 22.0 analysis, the differences before and after the test are compared by applying paired sample T test to normal distribution, and the differences are compared by applying rank and test to normal distribution, wherein P is less than or equal to 0.05, the differences are significant, if P is more than or equal to 0.05, the differences are not significant, the statistical method adopts double-tail detection, and the detection level alpha=0.05.
The test results are shown in tables 14 to 29:
table 14A comparison of results of water content in stratum corneum of subject and control subjects (unit: a.u.)
Table 15 results of percentage change in stratum corneum Water content of group A subjects
Cycle time | 1h | 2h | 4h |
Percent Change (%) | 141.18 | 135.40 | 139.06 |
Table 16B comparison of results of water content in stratum corneum of subject and control (unit: a.u.)
Table 17 results of percentage change in stratum corneum Water content of group B subjects
Cycle time | 1h | 2h | 4h |
Percent Change (%) | 139.20 | 133.74 | 136.09 |
Table 18C comparison of results of water content in stratum corneum of subject and control of subjects (unit: a.u.)
Table 19 results of percentage change in stratum corneum Water content of group C subjects
Cycle time | 1h | 2h | 4h |
Percent Change (%) | 76.78 | 69.49 | 47.89 |
Table 20D comparison of results of water content in stratum corneum of subject and control subjects (unit: a.u.)
Table 21 percent change results of stratum corneum Water content in group D subjects
Cycle time | 1h | 2h | 4h |
Percent Change (%) | 76.30 | 61.41 | 49.75 |
Table 22E comparison of results of water content in stratum corneum of subject and blank control (unit: a.u.)
Table 23 percent change results of stratum corneum Water content in group E subjects
Cycle time | 1h | 2h | 4h |
Percent Change (%) | 78.03 | 70.69 | 48.94 |
Table 24F comparison of results of water content in stratum corneum of subject and control subjects (unit: a.u.)
Table 25 percent change results of stratum corneum Water content in group F subjects
Cycle time | 1h | 2h | 4h |
Percent Change (%) | 71.98 | 60.27 | 47.05 |
Table 26G comparison of results of water content in stratum corneum of subject and control of subjects (unit: a.u.)
Table 27 percent change results of stratum corneum Water content in group G subjects
Cycle time | 1h | 2h | 4h |
Percent Change (%) | 85.45 | 99.69 | 40.18 |
Table 28H comparison of results of water content in stratum corneum of subject and control subjects (unit: a.u.)
Table 29 percent change results of stratum corneum Water content in group H subjects
Cycle time | 1h | 2h | 4h |
Percent Change (%) | 87.69 | 99.65 | 45.47 |
Tables 14 to 29 show that: the difference before and after the test is subjected to normal distribution by using SPSS 22.0 analysis, and the difference between the blank control area difference value of the group A and the blank control area difference value of the group B and the difference between the tested area difference value of the group A and the blank control area difference value of the tested area difference value of the group B are less than or equal to 0.05 when the difference between the blank control area difference value and the tested area difference value of the group A and the blank control area difference value of the tested area difference value of the group B and the tested area difference value of the tested area difference between the blank control area difference value and the tested area difference value of the tested area difference between the blank control area and the tested area difference between the blank control area and the tested area difference between the tested area and the tested area are less than or equal to 0.05 when the difference between the blank control area and the blank control area difference between the blank area and the tested area are 1h and; the difference between the blank control areas of the group C, the group D, the group E and the group F and the difference between the blank control areas of the group F and the tested areas are less than or equal to 0.05 at 1H, and P is more than 0.05 at 2H and 4H, which indicates that the water content of the stratum corneum is remarkably different before 1H compared with that of the tested samples without any product, the tested samples have moisturizing effect, no remarkable difference exists after 2H, the tested samples have no moisturizing effect, P is less than or equal to 0.05 at 1H and 2H of the group G and the group H, and P is more than 0.05 at 4H, which indicates that the tested samples have moisturizing effect before 2H and have no moisturizing effect after 4H.
In summary, the essence of application example 1 and the essence cream of application example 4 have more remarkable moisturizing effect in the test, and the duration of the moisturizing effect is longer, which indicates that the composite plant extract of the invention has more remarkable moisturizing effect and longer moisturizing time in the cosmetic than the composite plant extract and the single ginseng extract prepared by the common extraction method.
2) Skin elasticity test:
test object: 80 volunteers aged 18-60 years (without limitation for men and women, except for gestational and lactating women), healthy skin, no history of skin allergy, no other clinical trial at the test sites for nearly three months, and the 80 volunteers were randomly divided into 8 groups (designated as group a, group B, group C, group D, group E, group F, group G and group H) of 10 persons each.
The testing method comprises the following steps: the essence of application example 1 was used in group a, the essence of application example 4 was used in group B, the essence of comparative application example 1 was used in group C, the essence of comparative application example 3 was used in group D, the essence of comparative application example 2 was used in group E, the essence of comparative application example 4 was used in group F, the European style moisturizing and repairing stock of comparative application example 5 was used in group G, the European style Bei Sishui moisturizing and repairing cream of comparative application example 6 was used in group H, and the skin elasticity tester revismeter RV600 was used for measuring the measured parts at the same time before, after 1 week, after 2 weeks and after 4 weeks of use, respectively, continuously for 4 weeks.
The test results are shown in table 30:
table 30 skin elasticity test results
Note that: percent change in elasticity (%) = (n weeks for Rn-before Rn) x 100% before Rn.
As can be seen from table 30: the volunteers used the essence of application example 1 and the essence cream of application example 4, which showed the most remarkable increase in skin elasticity index after 4 weeks, and showed that the skin elasticity was greatly improved, indicating that the composite plant extract of the present invention was easier to penetrate and absorb in cosmetics, and increased skin elasticity and water content of horny layer than the composite plant extract and single ginseng extract prepared by the general extraction method.
3) Oxidative stress test:
the inspection principle is as follows: oxidative stress is one of the important causes of aging and injury of skin cells, and the excessive production of free radicals by oxygen metabolism of the body can lead to skin aging and induce the formation of skin wrinkles. Vitamin C (ascorbic acid) is an effective free radical scavenger that is converted to dehydroascorbic acid by stepwise electron supply to scavenge DPPH and like free radicals.
The testing method comprises the following steps:
a) Test samples were divided into 8 groups: the essence of application example 1 is used in group a, the essence of application example 4 is used in group B, the essence of comparative application example 1 is used in group C, the essence of comparative application example 3 is used in group D, the essence of comparative application example 2 is used in group E, the essence of comparative application example 4 is used in group F, the European style moisturizing and repairing stock of comparative application example 5 is used in group G, and the European style Bei Sishui moisturizing and repairing cream of comparative application example 6 is used in group H;
b) Accurately weighing a test sample and vitamin C, respectively adding a proper amount of absolute ethyl alcohol for dilution, shaking uniformly, preparing a series of concentrations of vitamin C solution by using absolute ethyl alcohol for standby, respectively mixing the test sample solution and the vitamin C solution with a series of concentrations with DPPH solution uniformly, standing at room temperature in a dark place for 30min, measuring absorbance at 515nm, taking vitamin C as a positive control, taking each group of samples for 2 times, and taking an average value.
The test results are shown in table 31:
TABLE 31 determination of DPPH radical scavenger of test samples
As can be seen from table 31: the essence of application example 1 and the essence of application example 4 have much higher scavenging rate on DPPH free radical than other control samples, i.e., application example 1 and application example 4 have the strongest antioxidant ability, indicating that the compound plant extract of the present invention has stronger antioxidant ability than the compound plant extract prepared by the general extraction method and the single ginseng extract.
4) Anti-glycation test:
the testing method comprises the following steps:
a) The test samples were divided into 8 groups, group a using the essence of application example 1, group B using the essence of application example 4, group C using the essence of comparative application example 1, group D using the essence of comparative application example 3, group E using the essence of comparative application example 2, group F using the essence of comparative application example 4, group G using the obex moisturizing and repairing stock solution of comparative application example 5, group H using the euro Bei Sishui moisturizing and repairing cream of comparative application example 6, and the 8 groups of samples were diluted into 10% aqueous solutions, respectively;
b) 1mL of sample and 1mL of fructose solution (1.5 mol/L) are added into a test tube under the aseptic condition, evenly mixed, incubated for 2 hours in a constant temperature incubator at 37 ℃, then BSA (bovine serum albumin) solution (30 mg/mL) and 1mL of BSA (bovine serum albumin) solution are added, all reactants are dissolved by using a phosphoric acid buffer solution containing 0.1% of sodium azide, an aminoguanidine with the same mass concentration is used as a positive representative, the phosphate buffer solution is used as a blank control, the blank control is placed into the incubator at a fixed temperature for reaction for 6 days at 37 ℃, the fluorescence intensity of the sample is measured under the conditions that the excitation wavelength is 370nm and the emission wavelength is 440nm, each group of measurement is carried out twice, Taking an average value, and calculating a calculation formula of the generation inhibition rate R of AGEs: r (%) = (1-F) A /F B ) X 100%, where F A For the fluorescence intensity of each sample group, F B Fluorescence intensity for the blank.
The test results are shown in table 32:
table 32 test sample for inhibition of fluorescent AGEs production
As can be seen from table 32: the highest inhibition ratio of the essence of application example 1 and the essence of application example 4 to fluorescent AGEs, namely the strongest anti-saccharification ability of application example 1 and application example 4, shows that the anti-saccharification ability of the composite plant extract of the invention is more prominent compared with the composite plant extract prepared by a common extraction method and a single ginseng extract.
5) Skin feel test:
test object: 80 volunteers aged 18 to 60 years (without limitation for men and women, except for women in gestation and lactation), skin health, no history of skin allergy, were randomly divided into 8 groups (designated as group a, group B, group C, group D, group E, group F, group H and group G) of 10 persons each.
The testing method comprises the following steps: the essence of application example 1 was used in group a, the essence of application example 4 was used in group B, the essence of comparative application example 1 was used in group C, the essence of comparative application example 3 was used in group D, the essence of comparative application example 2 was used in group E, the essence of comparative application example 4 was used in group F, the European style moisturizing and repairing stock solution of comparative application example 5 was used in group G, the European style Bei Sishui moisturizing and repairing cream of comparative application example 6 was used in group H, and the procedure was continued for 4 weeks, and each group was measured twice, taking the average value of each group.
The test results are shown in table 33:
TABLE 33 skin feel test results
Note that: the score of each item is 0-10 points, 0 points being worst, 10 points being best.
As can be seen from table 33: the essence of application example 1 and the essence of application example 4 have the highest scores, which show that the composite plant extract of the invention has good spreadability in cosmetics, is easy to absorb, is not sticky and is more easily accepted and favored by consumers compared with the composite plant extract prepared by a common extraction method and a single ginseng extract.
Furthermore, by performing the same test, it was found that: the effects of the composite plant extracts of examples 2 to 4 in terms of moisture retention, oxidation resistance, saccharification resistance, skin elasticity improvement, etc. were very similar to those of the composite plant extract of example 1.
The above examples are preferred embodiments of the present invention, but the embodiments of the present invention are not limited to the above examples, and any other changes, modifications, substitutions, combinations, and simplifications that do not depart from the spirit and principle of the present invention should be made in the equivalent manner, and the embodiments are included in the protection scope of the present invention.
Claims (5)
1. The composite plant extract is characterized by comprising the following components in percentage by mass:
Ginseng extract: 26% -68%;
wolfberry extract: 10% -20%;
tremella extract: 10% -20%;
radix Ophiopogonis extract: 5% -15%;
sugarcane root extract: 5% -15%;
1, 2-hexanediol: 1% -2%;
1, 2-pentanediol: 1% -2%;
the ginseng extract, the medlar extract, the tremella extract, the dwarf lilyturf tuber extract and the sugarcane root extract are prepared by solid state fermentation, enzymolysis and ultrafiltration;
the ginseng extract is prepared by the following steps: 1) Cleaning and drying ginseng, and then carrying out superfine grinding and screening to obtain ginseng powder; 2) Dispersing Ginseng radix powder with water, and sterilizing under high pressure to obtain solid Ginseng radix culture medium; 3) Uniformly mixing activated lactobacillus bacteria solution and sterilized sodium alginate solution, dripping into sterilized calcium chloride solution to form gel beads, and aging to obtain embedded strain particles; 4) Mixing the embedded strain particles with a solid ginseng culture medium, fermenting, adding water for dispersion, and centrifuging to obtain a supernatant to obtain ginseng fermentation liquor; 5) Adjusting the pH value of the ginseng fermentation liquor to 1.0-2.0, adding pepsin for primary enzymolysis, adjusting the pH value to 6.0-7.0, and adding papain for secondary enzymolysis to obtain the ginseng fermentation liquor for enzymolysis; 6) Inactivating enzyme of the enzymolysis Ginseng radix fermentation broth, and ultrafiltering to obtain Ginseng radix extract;
The medlar extract is prepared by the following steps: 1) Cleaning and drying the medlar, and then carrying out superfine grinding and screening to obtain medlar powder; 2) Dispersing the medlar powder with water, and then performing high-pressure sterilization to obtain a solid medlar culture medium; 3) Uniformly mixing the activated saccharomycete liquid and the sterilized sodium alginate solution, dripping the mixture into the sterilized calcium chloride solution to form gel beads, and aging to obtain embedded strain particles; 4) Mixing the embedded strain particles with a solid medlar culture medium, fermenting, adding water for dispersion, and centrifuging to obtain supernatant to obtain medlar fermentation liquor; 5) Adjusting the pH value of the medlar fermentation broth to 6.0-7.0, and then adding cellulase and pectase for enzymolysis to obtain the enzymatic medlar fermentation broth; 6) Inactivating enzyme of the enzymatic matrimony vine fermentation liquid, and performing ultrafiltration to obtain matrimony vine extract;
the tremella extract is prepared by the following steps: 1) Cleaning and drying tremella, and then carrying out superfine grinding and screening to obtain tremella powder; 2) Dispersing tremella powder with water, and then performing high-pressure sterilization to obtain a solid tremella culture medium; 3) Uniformly mixing the activated saccharomycete liquid, the activated lactobacillus liquid and the sterilized sodium alginate solution, dripping the mixture into the sterilized calcium chloride solution to form gel beads, and aging to obtain embedded strain particles; 4) Mixing the embedded strain particles with a solid tremella culture medium, fermenting, adding water for dispersion, and centrifuging to obtain a supernatant to obtain tremella fermentation liquor; 5) Adjusting the pH value of the tremella fermentation liquor to 6.0-7.0, and then adding cellulase, pectase and neutral protease for enzymolysis to obtain the tremella fermentation liquor for enzymolysis; 6) Inactivating enzyme of the zymolysis tremella fermentation liquid, and performing ultrafiltration to obtain tremella extract;
The ophiopogon root extract is prepared by the following method: 1) Cleaning and drying radix Ophiopogonis, and micronizing and sieving to obtain radix Ophiopogonis powder; 2) Dispersing radix Ophiopogonis powder with water, and performing high-pressure sterilization to obtain solid radix Ophiopogonis culture medium; 3) Uniformly mixing activated lactobacillus bacteria solution and sterilized sodium alginate solution, dripping into sterilized calcium chloride solution to form gel beads, and aging to obtain embedded strain particles; 4) Mixing the embedded strain particles with a solid ophiopogon culture medium, fermenting, adding water for dispersion, and centrifuging to obtain supernatant to obtain ophiopogon fermentation liquor; 5) Adjusting the pH value of the ophiopogon japonicus fermentation liquor to 6.0-7.0, and then adding cellulase and pectase for enzymolysis to obtain the enzymolysis ophiopogon japonicus fermentation liquor; 6) Inactivating enzyme of the enzymatic radix Ophiopogonis fermentation broth, and ultrafiltering to obtain radix Ophiopogonis extract;
the sugarcane root extract is prepared by the following steps: 1) Cleaning and drying the sugarcane roots, and carrying out superfine grinding and screening to obtain sugarcane root powder; 2) Dispersing the sugarcane root powder with water, and then performing high-pressure sterilization to obtain a solid sugarcane root culture medium; 3) Uniformly mixing activated lactobacillus bacteria solution and sterilized sodium alginate solution, dripping into sterilized calcium chloride solution to form gel beads, and aging to obtain embedded strain particles; 4) Mixing the embedded strain particles with a solid-state sugarcane root culture medium, fermenting, adding water for dispersion, and centrifuging to obtain supernatant to obtain sugarcane root fermentation liquor; 5) Adjusting the pH value of the sugarcane root fermentation liquor to 6.0-7.0, and then adding cellulase and pectase for enzymolysis to obtain the enzymatic hydrolysis sugarcane root fermentation liquor; 6) And (3) inactivating enzyme of the enzymatic hydrolysis sugarcane root fermentation liquor, and performing ultrafiltration to obtain the sugarcane root extract.
2. The compound plant extract of claim 1, wherein: the molecular weight cut-off of the ultrafiltration membrane adopted by the ultrafiltration is 1000 Da-2000 Da.
3. Use of the complex plant extract of claim 1 or 2 in cosmetics.
4. The essence is characterized by comprising the following components in percentage by mass:
humectant: 7% -12%;
chelating agent: 0.01 to 0.1 percent;
and (3) a thickening agent: 0.1 to 0.2 percent;
the complex plant extract of claim 1 or 2: 0.5% -20%;
preservative: 0.2% -1%;
water: 70% -90%.
5. The essence cream is characterized by comprising the following components in percentage by mass:
phase A:
humectant: 5% -10%; disodium EDTA: 0.01 to 0.1 percent; water: 60% -80%;
and B phase:
emulsifying agent: 1% -3%; oil ester: 5% -10%;
and C phase:
and (3) a thickening agent: 1% -2%;
and D phase:
the complex plant extract of claim 1 or 2: 0.5% -20%; preservative: 0.5 to 1.5 percent.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210931878.1A CN115252520B (en) | 2022-08-04 | 2022-08-04 | Composite plant extract and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210931878.1A CN115252520B (en) | 2022-08-04 | 2022-08-04 | Composite plant extract and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN115252520A CN115252520A (en) | 2022-11-01 |
CN115252520B true CN115252520B (en) | 2023-05-30 |
Family
ID=83748995
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210931878.1A Active CN115252520B (en) | 2022-08-04 | 2022-08-04 | Composite plant extract and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115252520B (en) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2011213660A (en) * | 2010-03-31 | 2011-10-27 | Naris Cosmetics Co Ltd | Antioxidant, ultraviolet hazard inhibitor and anti-photoageing cosmetic |
CN102321707A (en) * | 2011-09-30 | 2012-01-18 | 陕西科技大学 | Method for preparing gentio-oligosaccharide by using immobilized beta-glucosidase |
WO2022056891A1 (en) * | 2020-09-20 | 2022-03-24 | 湖州盛明生物科技有限公司 | Skin care lotion and preparation method therefor |
CN114344187A (en) * | 2022-01-10 | 2022-04-15 | 南宁荣港生物科技有限公司 | Chrysanthemum megatherum polypeptide composition and preparation method and application thereof |
CN114762732A (en) * | 2021-01-13 | 2022-07-19 | 梦芊科技知识产权有限公司 | Controlled release microspheres and anti-aging application thereof |
-
2022
- 2022-08-04 CN CN202210931878.1A patent/CN115252520B/en active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2011213660A (en) * | 2010-03-31 | 2011-10-27 | Naris Cosmetics Co Ltd | Antioxidant, ultraviolet hazard inhibitor and anti-photoageing cosmetic |
CN102321707A (en) * | 2011-09-30 | 2012-01-18 | 陕西科技大学 | Method for preparing gentio-oligosaccharide by using immobilized beta-glucosidase |
WO2022056891A1 (en) * | 2020-09-20 | 2022-03-24 | 湖州盛明生物科技有限公司 | Skin care lotion and preparation method therefor |
CN114762732A (en) * | 2021-01-13 | 2022-07-19 | 梦芊科技知识产权有限公司 | Controlled release microspheres and anti-aging application thereof |
CN114344187A (en) * | 2022-01-10 | 2022-04-15 | 南宁荣港生物科技有限公司 | Chrysanthemum megatherum polypeptide composition and preparation method and application thereof |
Non-Patent Citations (1)
Title |
---|
百里香抑菌物质的提取工艺优化及活性研究;王娣;柯春林;曹珂珂;李妍;;中国调味品(04);93-100 * |
Also Published As
Publication number | Publication date |
---|---|
CN115252520A (en) | 2022-11-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109453087B (en) | Whitening skin-penetrating lotion, preparation method thereof and whitening cosmetic additive | |
CN109350579B (en) | Whitening cosmetic additive, whitening skin-refreshing lotion and preparation method thereof | |
CN111643411B (en) | Anti-aging composition and application thereof | |
CN115317429A (en) | Composition containing recombinant collagen and having repairing and relieving effects, eye cream containing composition, preparation method and application | |
CN104306323A (en) | Cordyceps-militaris-ingredient contained eye cream and preparing method of cordyceps-militaris-ingredient contained eye cream | |
CN109394640B (en) | Enzyme skin care composition and application thereof | |
CN114134088A (en) | Choerospondias axillaris fermentation product and preparation method and application thereof | |
CN104434760A (en) | Facial cream containing ingredient of cordyceps militaris and preparation method thereof | |
CN114099393A (en) | Composition with tightening and anti-aging effects and preparation method and application thereof | |
CN114272184A (en) | Polypeptide composition, anti-aging repair eye cream containing polypeptide composition and preparation method of anti-aging repair eye cream | |
CN108721192A (en) | A kind of extracted form natural plant essence facial mask liquid and its extraction process | |
CN115252520B (en) | Composite plant extract and application thereof | |
CN111821230A (en) | Anti-allergy repairing cosmetic composition and application thereof | |
CN115364039B (en) | Acne skin repair composition and application thereof | |
CN115317410B (en) | Fermentation oil for relieving, preserving moisture and enhancing cell viability and preparation method and application thereof | |
CN114159333B (en) | Myobase liquid and preparation method thereof | |
KR102381645B1 (en) | Cosmetic Composition Comprising Poria cocos Fermentation Extract | |
CN113081924B (en) | Antioxidant composition, preparation method and application | |
CN111991293B (en) | Skin care essence lotion for treating and repairing sensitive acne skin and preparation method thereof | |
CN115137675A (en) | Compound plant extract with moisturizing effect and application thereof | |
CN113116767B (en) | Skin-refreshing lotion, preparation method thereof and collagenase inhibitor | |
CN112972323A (en) | Hemp leaf essence and preparation method thereof | |
CN111700830A (en) | Composition and application thereof in preparation of anti-glycosylation cosmetics | |
CN111265443A (en) | Anti-aging essence skin care lotion containing codonopsis pilosula extract and preparation method of anti-aging essence skin care lotion | |
CN104434759A (en) | Eye cream containing ingredient of cordyceps militaris and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |